Whether it’s a one-off or a sign of things to come, Bharat Aggarwal, the MD Anderson scientist at the center of a blogospheric storm—and an institutional investigation—over the validity of his data, has had a paper withdrawn by the journal Cancer Letters.The article,”Cardamonin Inhibits Osteoclastogenesis Induced by Tumor Cells Through Interruption of the Signaling Pathway Activated by Receptor Activator of NF-κB Ligand,” was published in December. According to the notice: This article has been withdrawn at the request of the author(s) and/or editor.
MD Anderson researcher Aggarwal loses paper in Cancer Letters …
Sursa:
MD Anderson researcher Aggarwal loses paper in Cancer Letters …